Cargando…

531. Reducing Inappropriate Hospital-Acquired Clostridium difficile Diagnoses

BACKGROUND: Clostridium difficile infection (CDI) rates suddenly increased 30%, coincident with adoption of a new electronic medical record (EMR) and a reduction in our Environmental Services (ES) workforce. A Targeted Assessment for Prevention (TAP) report suggested we had the greatest opportunity...

Descripción completa

Detalles Bibliográficos
Autores principales:	Duncan, Robert, Eyre-Kelly, Jane, Cartagena, Jose, Gawlick, Melissa, Delacy, Rosemarie, Villanueva, Andrew
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2018
Materias:	Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6253580/ http://dx.doi.org/10.1093/ofid/ofy210.540

Ejemplares similares

520. Reducing Inappropriate Clostridium difficle Testing by Empowering Nurses
por: LeRose, Jennifer, et al.
Publicado: (2018)

1624 Risk Factors for Hospital-Acquired Clostridium difficile
por: Knepper, Bryan, et al.
Publicado: (2014)

177. Use of Electronic Best Practice Alert (BPA) to Reduce Inappropriate Testing for Clostridium difficile infection (CDI) at a Tertiary Care Center
por: Mills, John P, et al.
Publicado: (2018)

519. Longer Length of Antibiotic Therapy for Community-Acquired Pneumonia and Risk of Clostridium difficile Infection
por: Yi, Sarah H, et al.
Publicado: (2018)

2344. Evaluation of a Best Practice Alert (BPA) to Reduce Inappropriate Testing for Clostridium difficile Infection (CDI) Within a Multi-Hospital System
por: Dare, Ryan K, et al.
Publicado: (2019)

1794 Appropriate Antibiotic Therapy is Associated with Reduced Risk of Community Acquired Clostridium difficile Infection
por: Ge, Ivy Y., et al.
Publicado: (2014)

Impact of Electronic Hand Hygiene Monitoring on Hospital-Acquired Clostridium difficile Infection Rates
por: Knepper, Bryan, et al.
Publicado: (2017)

485. On- and Post-Antibiotic Effects on the Risk of Hospital-Acquired Clostridium difficile Infection (CDI)
por: Stevens, Vanessa, et al.
Publicado: (2018)

517. Impact of Doxycycline in Place of Azithromycin for Community-Acquired Pneumonia on Clostridium difficile Infections
por: John, Jamie, et al.
Publicado: (2018)

1501. Risk Factors for Clostridium difficile Infection in Patients Hospitalized with Community-Acquired Pneumonia
por: Deshpande, Abhishek, et al.
Publicado: (2019)

A Successful Strategy to Reduce Hospital-Onset Clostridium difficile
por: Bruno-Murtha, Lou Ann, et al.
Publicado: (2017)

514. The Effect of Probiotics on the Incidence of Clostridium difficile
por: Saltzman, Temima, et al.
Publicado: (2018)

Etiology of Infectious Diarrhea in Patients Tested for Clostridium difficile: If It Isn’t Clostridium difficile, What Is It?
por: Kwon, Jennie H, et al.
Publicado: (2017)

469. Validation and Characterization of Community-Acquired Clostridium difficile Infections from the Quebec C. difficile Infection Surveillance Program (QCISP)
por: Kazadi-Lukusa, Aimé, et al.
Publicado: (2018)

1990. A Strategy of Mandatory Infectious Disease Consultations on Hospital-acquired Clostridium difficile Infection and Antimicrobial Utilization
por: Hou, Cindy, et al.
Publicado: (2019)

1646 Evidence of hospital-associated Clostridium difficile transmission between patients with asymptomatic carriage and patients with Clostridium difficile infection
por: Galdys, Alison, et al.
Publicado: (2014)

Probiotics to Reduce Clostridium difficile Infection: Clinical Experience in a Tertiary Care Center
por: Box, Maggie, et al.
Publicado: (2017)

515. Estimating the Effect of Proton Pump Inhibitor Stewardship in Reducing Clostridium difficile Transmission
por: Lofgren, Eric, et al.
Publicado: (2018)

The Impact of Diagnostic Stewardship on Clostridium difficile Infections
por: Bischoff, Werner, et al.
Publicado: (2017)

Implementation of Electronic Medical Record Hard Stop Alerts for Inappropriate Clostridium difficile Tests in Academic and Community Hospital Setting; Impact on Testing Rates and Clinical Outcomes
por: Rock, Clare, et al.
Publicado: (2017)

Enhanced Cleaning and Education to Prevent Transmission of Clostridium difficile in Pediatrics
por: Aslam, Anoshé, et al.
Publicado: (2017)

1645 Do asymptomatic carriers of toxigenic Clostridium difficile identified through inappropriate testing represent a significant risk for transmission?
por: Kundrapu, Sirisha, et al.
Publicado: (2014)

Effect of Leadership Commitment and Education on Antimicrobial Use and Hospital-Acquired Clostridium difficile infection rates at a Community Hospital
por: Smoke, Steven, et al.
Publicado: (2017)

1988. Impact of a Novel Pharmacist Practice Model on Antimicrobial Usage and Hospital-acquired Clostridium difficile (HACDI) Rates
por: Pourgolafshan, Pegah, et al.
Publicado: (2019)

Clostridium difficile: Investigating Transmission Patterns Between Symptomatic and Asymptomatic Patients Using Whole Genome Sequencing
por: Kong, Ling Yuan, et al.
Publicado: (2017)

Community-Acquired Clostridium difficile Infection, Queensland, Australia
por: Furuya-Kanamori, Luis, et al.
Publicado: (2016)

A Multi-Faceted Antimicrobial Stewardship Program (ASP) Intervention Using Clinical Pharmacists Reduces Antibiotic Use and Hospital-Acquired Clostridium difficile Infection (HA-CDI)
por: Boyd, Anthony M, et al.
Publicado: (2017)

Weight Changes in Fecal Microbiota Transplant for Clostridium difficile
por: Hussam, Dina, et al.
Publicado: (2017)

Comparison of Fidaxomicin and Vancomycin for Recurrent Clostridium difficile Colitis
por: Khoo, Teresa, et al.
Publicado: (2017)

536. Clostridium difficile Colonization in the First Year of Life
por: Clayton, Jason A, et al.
Publicado: (2018)

526. An EMR-Based Diagnostic Stewardship Intervention for GI mPCR Aimed at Reducing Inappropriate C. difficile Tests
por: Newman, Margaret E, et al.
Publicado: (2018)

Multidrug Resistance in Rat Colon Carcinoma Cell Lines CC531, CC531(mdr+) and CC531(rev)
por: Gheuens, Eric, et al.
Publicado: (1993)

Epidemiology of Clostridium difficile infection Among Patients with Newly Diagnosed or Relapsed Acute Leukemia: A Single-center Experience
por: Garcia, Alexandra Franco, et al.
Publicado: (2017)

490. Comparison of Clostridium difficile Infection Outcomes by Diagnostic Testing Method
por: Guh, Alice, et al.
Publicado: (2018)

Endogenous Serum IgG Antibodies to Clostridium difficile Toxin B Are Associated with Protection against C. difficile Infection Recurrence
por: Kelly, Ciaran P, et al.
Publicado: (2017)

Efficacy of Oral Vancomycin, Oral Metronidazole, or IV Metronidazole Prophylaxis at Reducing the Risk of Clostridium difficile Recurrence
por: O’Connell, Matthew, et al.
Publicado: (2017)

Tetracyclines are Associated with a Reduced Risk of Clostridium difficile Infection: A Systematic Review and Meta-analysis
por: Tariq, Raseen, et al.
Publicado: (2017)

507. Degree of Concordance of Clostridium difficile Strains in Adults with Community-Associated C. difficile Infection and Infants With C. difficile Colonization
por: Clayton, Jason A, et al.
Publicado: (2018)

The Challenging Conundrum of Diagnosing and Managing Clostridium difficile Infection
por: Gerding, Dale N., et al.
Publicado: (2017)

Risk Factors for Community-Associated Clostridium difficile Infection in Children
por: Weng, Mark, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_odcrvr1cebheru8alipg7j9bqq